Lumakras Improves Outcomes, Quality of Life in Patients With Lung Cancer Subtype
September 14th 2022Lumakras outperformed chemotherapy in reducing the risk of progression or death and improving quality of life for patients with KRAS G12C-mutated non-small cell lung cancer, study results showed.
Read More
Longer Hormone Therapy After Main Treatments Delays Prostate Cancer Metastasis
September 13th 2022Two years of the hormone treatment androgen-deprivation therapy (ADT) after radiotherapy and radical prostatectomy tended to improve metastasis-free survival for patients with prostate cancer, study results showed.
Read More
Tumor-Infiltrating Lymphocyte Decreases Death Risk in Unresectable Skin Cancer
September 13th 2022The use of a tumor-infiltrating lymphocyte therapy led to better outcomes than treatment with Yervoy in patients with unresectable, treatment-refractory stage 3/4 melanoma, a type of skin cancer, study results showed.
Read More